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Atherosclerosis	and	Antioxidants	
Yehoshua	Lewis	
Abstract:	
Cellular	lipid	oxidation	is	a	known	cause	for	the	cascade	leading	to	the	formation	of	lipid	laden	
foam	 cells,	 which	 can	 cause	 of	 atherosclerosis.	While	 statins	 and	 antioxidants	 have	 recently	
come	 under	 question	 in	 the	 amelioration	 of	 atherosclerosis,	 Flavonoids	 have	 recently	 been	
touted	as	a	powerful	antioxidant	and	suppresser	of	atherosclerosis.	This	paper	will	attempt	to	
show	 why	 statins	 and	 vitamin	 E	 have	 come	 under	 scrutiny,	 and	 how	 the	 desired	 effects	 of	
Flavonoids	can	be	attributed	to	the	role	 it	plays	 in	 increased	paraoxonase-1	activity	(a	known	
anti	 inflammatory	associated	with	HDL),	decreased	C-	Reactive	protein	activity,	and	 increased	
nitric	oxide	(NO)	in	endothelial	cells	among	other	factors.		
Introduction:	
Coronary	artery	disease	(CAD)	is	the	leading	cause	of	death	in	the	United	States	every	year.	According	to	
the	 Center	 for	 Disease	 Control	 and	 the	 National	 Center	 for	 Health	 Statistics,	 data	 for	 the	 year	 2004	
indicate	that	heart	disease	killed	652,486	people	(U.S.	DEPARTMENT	OF	HEALTH	AND	HUMAN	SERVICES,	
2008).	This	is	nearly	100,000	more	than	the	second	leading	cause	of	death	in	the	United	States,	cancer.	
Atherosclerotic	plaque	build-up	 in	the	arteries	 is	the	cause	of	CAD,	and	has	been	the	primary	focus	of	
scientists	 in	 search	 of	 a	 cure	 for	 CAD.	Needless	 to	 say,	much	 research	 has	 been	 done	 on	 finding	 the	
causes	of	heart	disease	and	developing	drugs	that	inhibit	its	development.	Other	then	pharmacological	
products,	there	is	a	very	large	body	of	research	into	more	natural	remedies	for	atherosclerosis,	including	
antioxidants	 such	 as	 vitamin	 E	 that	 have	 been	 touted	 as	 providing	 protection	 against	 lipid	 oxidation.	
Recently,	 however,	 there	 is	 a	 growing	body	of	 evidence	 that	 statins	 and	antioxidant	 supplementation	
may	not	be	beneficial	as	thought.	In	contrast,	Flavonoids,	by	operating	under	mechanisms	different	then	
antioxidants	and	statins,	offers	new	hope	in	the	treatment	of	atherosclerosis.			
Coronary	Artery	Disease:	
While	there	are	many	factors	that	contribute	to	CAD,	there	are	a	number	of	factors	specifically	related	
to	atherosclerosis	that	play	a	key	role	in	its	development.	Atherosclerosis	is	a	progressive	disease	of	the	
arteries	and	is	the	result	of	plaque	buildup	in	the	arteries	driven	by	the	
uptake	of	cholesterol	in	artery	walls	(Medline	Plus,	2007).		Lipids	are	not	
water	 soluble,	and	must	 rely	on	 lipoproteins,	produced	 in	 the	 liver	and	
small	 intestines,	 in	 order	 to	be	 transported	 in	 the	blood.	By	 combining	
lipids	with	lipoproteins,	the	lipids	are	able	to	be	transported	either	to	the	
liver	 for	 elimination,	 or	 from	 the	 liver	 for	 the	 production	 of	 steroid	
hormones,	 bile	 salts,	 and	 for	 cell	 membrane	 repair.	 The	 two	 major	
lipoproteins	 involved	 in	 these	 functions	 are	 low-density	 lipoproteins	
(LDL),	 and	 high-density	 lipoprotein	 (HDL);	 with	 LDL	 being	 responsible	
Figure	1.	Dissected	aorta	with	
atherosclerotic	lesions	(Ewing,	
1972)	
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lipid	 transport	 from	 the	 liver,	 and	 HDL	 being	 responsible	 for	 transport	 of	 lipids	 to	 the	 liver	 for	
elimination	(Tortora	&	Derrickson,	2006).		
Plaque	formation	begins	with	the	aggregation	of	excess	LDL	 in	 the	 inner	 layer	of	arterial	walls	
where	 the	 lipoproteins	 are	 subject	 to	 oxidation.	 In	 response,	 substances	 released	 by	 endothelial	 and	
smooth	muscle	cells	attract	macrophages	that	ingest	the	oxidized	LDL	forming	plaque.	So	much	so,	that	
the	 macrophages	 take	 on	 a	 foamy	 appearance	 under	 the	 microscope	 (foam	 cells).	 	 Additionally,	
lymphocytes	 (T	 cells)	 follow	 the	 macrophages	 into	 the	 arterial	 wall	 and	 increase	 the	 streaks	 in	 the	
arterial	walls.	Subsequently,	the	macrophages	cause	the	migration	of	the	middle	 layer	of	the	artery	to	
the	 surface	 of	 the	 plaque	 thus	 separating	 it	 from	 the	 bloodstream,	 but	 also	 narrowing	 the	 arterial	
lumen.	In	the	event	that	the	cap	over	the	plaque	bursts,	the	T	cells	stimulate	the	foam	cells	to	produce	
tissue	 factor	 (TF),	 which	 ultimately	 leads	 to	 blood	 clot	 formation	 and	 possible	 obstruction	 of	 the	
coronary	 artery,	 resulting	 in	 myocardial	 infarction	 (MI).	 Other	 factors	 currently	 being	 considered	 by	
researchers	include	C-reactive	proteins,	which	bind	to	damaged	cells	and	assist	in	phagocytosis,	clotting	
factors,	 and	 the	 amino	 acid	 homocysteine	 that	 promotes	 platelet	 aggregation	 (Tortora	&	 Derrickson,	
2006).		
Statins:	
In	 order	 to	 treat	 atherosclerosis,	
scientists	 have	 focused	 their	 attention	 on	
reducing	 the	 amount	 of	 cholesterol	
available	 in	 the	 bloodstream	 for	 oxidation	
with	the	use	of	statin	drugs.	
In	 the	 1960’s	 (Endo,	 1992)	 scientists	
discovered	 that	 when	 cholesterol	 is	
completely	 eliminated	 from	 the	 diet,	 the	
liver	 takes	 over	 and	 produces	 up	 to	 82%	
percent	 of	 the	 required	 cholesterol.	
However,	when	cholesterol	 is	added	to	the	
diet	 the	 synthesis	 of	 cholesterol	 is	 almost	
completely	 suppressed.	 They	 discovered	
that	 the	 production	 or	 suppression	 of	
cholesterol	 was	 in	 response	 to	modulation	
by	 HMG-CoA	 reductase	 which	 modulates	
the	 inhibition	 of	 the	 Mevalonate	 pathway	
of	cholesterol	synthesis	 (Figure	2).	Through	
modulating	 this	 enzyme	 they	were	 able	 to	
alter	 the	 production	 of	 cholesterol.	 Thus	
was	 born	 the	 first	 statin	 drugs.	 However,	 there	
are	medical	 researchers	 who	 challenge	 the	 claim	 that	 statin	 drugs	 actually	 lower	 the	 risk	 factors	 for	
myocardial	 infarction	 (MI).	 In	 a	 scathing	 review	 of	 studies	 purporting	 to	 show	 that	 by	 lowering	
Figure	2.	Mevalonate	pathway	of	cholesterol	synthesis	
(Chemistry	Daily,	2007)		
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cholesterol	with	 statin	 drugs	mortality	 rates	 are	 decreased,	 Kauffman	 (Kauffman,	 2007)	 cites	 a	 study	
carried	out	in	New	York	City	of	a	group	of	2,277	people	with	the	median	age	of	76	who	were	studied	for	
a	period	of	ten	years.	What	he	found	was	that	“The	chance	of	dying	was	twice	as	great	in	subjects	with	
the	 lowest	 quartile	 of	 total	 cholesterol	 (TC)	 or	 LDL-C	 levels,	 compared	 with	 those	 in	 the	 highest	
quartile”.	 Kauffman	 goes	 on	 to	 cite	 another	 study	which	 shows	 that	 for	men	 aged	 35-57	 “all	 cause”	
mortality	 rates	 increased	 for	 those	 with	 a	 TC	 of	 <170	 mg/dL	 and	 the	 risk	 increased	 further	 as	 TC	
decreased	 to	 <140	 mg/dL	 to	 the	 same	 levels	 seen	 for	 subjects	 with	 extremely	 high	 cholesterol	
>300mg/dL.	 Kaufmann	 flatly	 states	 “Serum	 TC	 level	 is	 not	 even	 predictive	 of	 cardiovascular	 disease	
(CVD)	 in	men	over	 the	age	of	47”.	Kauffman	 is	not	alone	 in	 challenging	 the	use	of	 statins;	 the	British	
Medical	 Journal	 (Ravnskov	 et	 al.,	 2006)	 also	 challenges	 its	 widespread	 use,	 safety	 and	 efficacy.	 This	
raises	serious	questions	about	how	the	medical	community	is	facing	the	challenge	of	CAD.	
Oxidation:	
While	 statins	 focus	 on	 reducing	 TC	 as	 a	 remedy	 to	 the	 formation	 of	 atherosclerosis,	 there	 is	
another	very	important	juncture	in	the	formation	of	atherosclerosis	that	has	been	the	focus	of	research,	
namely	oxidative	stress	caused	by	free	radicals	and	reactive	oxygen	species	(ROS).	ROS	and	free	radicals	
are	 injurious	 to	 lipids,	DNA,	and	proteins	 if	 left	unchecked	by	 the	bodies’	native	defense	mechanisms	
(Davis,	1995).	What	are	ROS	and	free	radicals	and	why	are	they	so	important?		
Examples	 of	 ROS	 include	 hydrogen	 peroxide	 (H2O2),	 hypochlorous	 acid	 (HClO).	 Free	 radicals	
include	superoxide	anion	(·O2−)	and	hydroxyl	radical	(·OH)	(Davis,	1995).	One	source	of	the	free	radical	
superoxide	 anion	 (·O2−)	 is	 that	 produced	 by	 the	 NADH/NADPH	 oxidase	 in	 macrophages	 during	 the	
uptake	of	LDL	(Runge,	1999).	The	superoxide	is	formed	during	the	electron	transport	chain	(ETS)	when	
the	 reduction	 of	 coenzyme	Q	 in	 complex	 III	 forms	 the	 unstable	 Q·−	 radical	 which	 can	 leak	 electrons	
directly	 to	 oxygen	 instead	 of	 cascading	 down	 the	 rest	 of	 the	 ETS	 thus	 forming	 superoxide	 radicals	
(Holbrook,	2000).		
Considering	 that	1%	 -	 15%	of	O2	 respired	by	mammals	undergoes	 the	 superoxide	anion	 (·O2−)	
state	(McGraw-Hill's	Access	Science),	there	is	also	ample	opportunity	to	form	undesired	side	reactions.		
An	example	of	a	side	reaction	causing	oxidative	stress	results	when	superoxide	reacts	with	nitric	oxide	
(NO)	to	form	peroxynitrite	(·O2−	+	·NO	→	ONO2−).	Peroxynitrite	then	reacts	as	a	strong	oxidizing	agent	
with	lipids,	DNA,	and	proteins.	Superoxide	and	NO	individually	can	both	be	efficiently	removed	from	the	
body.	Superoxide	reacts	with	hydrogen	in	the	presence	superoxide	dismutase	(SOD)	to	form	oxygen	and	
hydrogen	peroxide	(2·O2−	+	2H+	 	 	→	O2	+	H2O2),	which	can	then	be	converted	by	catalase	to	water	and	
oxygen.	 NO	 is	 rapidly	 removed	 by	 its	 diffusion	 through	 tissues	 into	 red	 blood	 cells.	 However,	 when	
compared	with	SOD,	the	kinetics	and	thermodynamics	during	a	reaction	of	NO	and	superoxide	favor	the	
formation	 of	 peroxynitrite	 -	 resulting	 in	 the	 inevitable	 formation	 of	 a	 highly	 reactive	 oxidizing	 agent.	
Peroxynitrite	acts	as	a	potent	oxidizing	agent	towards	LDL	which	then	becomes	the	target	for	scavenger	
cells	 and	 the	 formation	 of	 foam	 cells.	 	 Various	 studies	 have	 also	 shown	 that	 LDL	 can	 be	 oxidized	 by	
peroxynitrite	even	in	the	presence	of	endogenous	lipophilic	antioxidants	(Pacher	et	al.,	2007).		
Another	 source	 of	 oxidation	 is	 the	 Hydroxyl	 radicals	 (•OH)	 that	 are	 produced	 in	 the	 iron	
catalyzed	Haber-Weiss	reaction.	The	Haber-Weiss	reaction	(Koppenol,	2001)	was	first	discovered	in	the	
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early	 1930’s	 by	 Fritz	 Haber	 and	 Josef	 Weiss	 and	 proceeds	 as	 follows:	 Recalling	 that	 1%-15%	 of	 O2	
respired	 by	 mammals	 undergoes	 the	 superoxide	 anion	 (·O2−)	 state,	 we	 can	 propose	 the	 following	
reactions:			
Fe3+	+	•O2−	→	Fe2+	+	O2,	
Followed	by	the	Fenton	reaction:	
Fe2+	+	H2O2	→	Fe3+	+	OH−	+	•OH,	
For	a	net	reaction	of:	
•O2-	+	H2O2	→	•OH	+	HO-	+	O2.	
Hydroxyl	radicals	are	short	lived	in	vivo,	(Approx	10-9	s)	and	are	highly	reactive	(Yan	et	al.,	2005).	
They	also	cannot	be	enzymatically	removed	because	of	 its	short	half	 life	and	tends	to	react	extremely	
quickly	with	whatever	is	in	its	vicinity	including:	carbohydrates,	nucleic	acids,	lipids,	and	amino	acids.		
The	limitations	of	this	process	are	inherent	in	that	it	requires	Iron	III	in	order	to	proceed,	and	the	
blood	 plasma	 protein	 Transferrin	 is	 very	 effective	 at	 scavenging	 free	 iron,	 making	 it	 unavailable	 for	
reduction.	However,	if	there	is	a	buildup	of	iron	either	due	to	dietary	Iron	overload	or	any	other	multiple	
of	diseases,	it	can	outstrip	the	ability	of	Transferrin	to	perform	properly	and	results	in	the	production	of	
free	radicals	(Fouad,	2008).		
Antioxidants:	
As	the	oxidation	of	lipids	form	a	key	step	in	the	formation	of	atherosclerosis,	it	should	also	lead	
to	 the	 conclusion	 that	 “antioxidants”	 offer	 protection	 against	 lipid	 oxidation.	 However,	 the	 more	
research	 that	 is	 being	 done,	 the	more	 it	 becomes	 clear	 that	 exogenous	 sources	 of	 antioxidants	 have	
questionable	 effects	 in	 vivo.	 The	 field	 of	 antioxidants	 is	 very	 broad	 and	 can	 be	 the	 subject	 of	 many	
papers,	but	just	to	scratch	the	surface;	antioxidants	can	be	broken	down	into	metabolite	and	enzymatic	
categories	as	well	as	lipid	soluble	and	water	soluble.	The	difference	between	them	is	their	mechanism	as	
well	as	site	of	action.	For	example:	 lipid	soluble	antioxidants	act	 in	cell	membranes,	and	water	soluble	
antioxidants	 act	 in	 the	 blood	 plasma	 and	 cytoplasm.	 Lipid	 soluble	 antioxidants	 include	 vitamin	 E	 and	
coenzyme	Q	(Q10).	Water	soluble	antioxidants	include	ascorbic	acid	(vitamin	C),	glutathione,	lipoic	acid,	
uric	 acid,	 and	 polyphenols	 (Flavonoids,	 tannins).	 Enzymatic	 antioxidants	 include	 the	 previously	
mentioned	SOD,	catalase,	as	well	as	glutathione	among	others	(Sies,	1997).		
Vitamin	E	 is	a	potent	antioxidant	and	some	research	has	shown	that	 it	can	regulate	HMG-CoA	
reductase	(Pal	et	al.,	2003;	Parker,	1993).		Vitamin	E	is	the	name	for	a	group	of	four	tocopherols	and	four	
tocotrienols,	of	which	the	most	 interesting	to	scientists	 is	 the	α-tocopherol	variety	because	of	 its	high	
bioavailability.	Vitamin	E	is	the	main	lipid-soluble	antioxidant	in	the	body	and	it	works	in	cell	membranes	
where	it	prevents	the	propagation	of	free	radical	reactions	(Herrera	&	Barbas,	2001).		
Because	vitamin	E	is	lipid	soluble,	when	absorbed	vitamin	E	is	packaged	in	Chylomicrons	(large	
lipoprotein	 particles)	 that	 are	 produced	 in	 the	 absorptive	 cells	 in	 the	 small	 intestine.	 They	 are	 then	
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secreted	via	exocytosis	into	lacteals	of	the	lymphatic	system	and	delivered	into	the	circulatory	system	at	
the	juncture	of	the	thoracic	duct	and	the	left	subclavian	where	they	are	transported	to	the	liver.	At	the	
liver,	 lipoprotein	 lipase	 (LPL)	 induces	 the	unloading	of	some	of	 the	chylomicrons	 into	the	extrahepatic	
tissue	 and	 the	 remainder	 chylomicrons	 transports	 the	 tocopherols	 into	 the	 liver.	 Here,	 “α-tocopherol	
transfer	protein"	incorporates	α-tocopherol	into	very	low	density	lipoprotein	(VLDL)	the	excess	of	which	
is	excreted	into	the	bile	duct.	The	α-tocopherol	binded	VLDL	is	then	transported	into	circulation	where	it	
is	converted	to	LDL	again	by	the	action	of	LPL.	The	α-tocopherol	is	then	taken	up	by	the	endothelial	cell	
membrane	by	the	uptake	of	LDL	via	cell	receptors	(Herrera	&	Barbas,	2001).		
Once	in	the	cell	membrane,	α-tocopherol	can	act	as	a	terminator	to	lipoprotein	oxidation	chain	
reaction	as	follows:		
Where	“I”	is	the	initiator	and	“LH”	is	the	fatty	 acid	
and	L•	is	formed	from	the	fatty	acid	
I	+	LH	→	L•	+	IH			[1]	
Propagation	continues	as	follows:			
L•	+	O2	→	LOO•	[2]	
LOO•	+	LH	→	LOOH	+	L•	[3]	
(See	Figure	3)	
Termination	occurs	when	tocopherol	“TO”	
breaks	the	chain	reaction:	
LOO•	+	TOH	→	LOOH	+	TO•	[4]	
The	 tocopheroxyl	 radical	 then	 reacts	 with	
another	 peroxyl	 radical	 to	 form	 tocopheryl	
quinine	 (Q10)	 and	 thereby	 arresting	 the	 chain	
reaction	(Wolf,	2005).		
As	 with	 almost	 every	 system	 in	 the	 body,	 vitamin	 E	 does	 not	 function	 in	 isolation	 but	 is	 part	 of	 an	
antioxidant	 network	 in	 which	 vitamin	 E	 can	 be	 synthesized	 from	 vitamin	 C	 and	 thiol	 redox	 cycles	
involving	 glutathione	 and	 lipoic	 acid.	 (See	 attachment).	 Vitamin	 C	 has	 pro-oxidant	 properties	 as	 well	
because	of	 its	ability	 to	 reduce	metal	 ions	via	 the	Fenton	 reaction	which	can	be	a	 source	of	oxidative	
stress.	However,	this	is	thought	to	be	of	minor	significance	as	compared	with	its	antioxidant	properties	
(FREI,	1999).				
On	the	other	front,	research	has	shown	that	vitamin	E,	specifically	tocotrienols,	can	modulate	HMG-CoA	
reductase	similar	way	to	that	done	by	statins	as	discussed	previously.	(Parker	et	al.,	1993)	
Figure	3.	The	free	radical	mechanism	of	lipid	
peroxidation	
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A	number	of	 studies	showed	this	effect	 in	mammals.	 In	one	study	hyperlipidemic	pigs	given	a	
diet	 rich	 in	 tocotrienols	 showed	 a	 marked	 decrease	 in	 plasma	 concentrations	 of	 cholesterol,	
apolipoprotein	B	(required	in	the	formation	of	LDL),	thromboxane	B2	and	platelet	factor	4(both	required	
for	blood	coagulation),	indicating	a	protective	effect	on	endothelium	and	platelet	aggregation	(Qureshi	
et	al.,	1991).	There	have	been	some	conflicting	results	 in	similar	trials	 in	humans;	however,	those	may	
be	attributed	 to	plasma	 levels	of	 tocotrienols	and	not	 to	 the	efficacy	of	 the	 compound	 (Packer	et	al.,	
2001).	It	would	thus	seem	that	by	ingesting	vitamin	E	one	would	be	able	to	take	concrete	measures	in	
arresting	the	propagation	of	atherosclerosis.		
However,	 a	 recent	 Meta	 analysis	 by	 The	 Cochrane	 Collaboration	 -	 of	 studies	 proving	 the	
remedial	effects	of	vitamin	E	as	well	as	other	antioxidants	-	has	not	supported	those	results.	Not	only	did	
the	ingestion	of	exogenous	antioxidants	not	prove	to	be	beneficial	but	has	also	shown	to	be	detrimental.	
The	 study	 included	 232,550	 participants	 who	 were	 “randomised	 to	 antioxidant	 supplements	 (beta-
carotene,	vitamin	A,	vitamin	C,	vitamin	E,	and	selenium)	versus	placebo	or	no	intervention”.	“A	total	of	
17,880	of	 136,023	participants	 (13.1%)	 randomised	 to	 antioxidant	 supplements	 and	 10,136	of	 96,527	
participants	(10.5%)	randomised	to	placebo	or	no	intervention	died.	In	the	analyses	of	the	trials	with	low	
risk	of	bias,	beta-carotene,	vitamin	A,	and	vitamin	E	significantly	 increased	mortality.”	The	study	 flatly	
states	that	there	is	no	evidence	to	support	antioxidant	supplementation.	This	study	brings	into	question	
the	widespread	use	of	antioxidants	as	a	remedial	and/or	prophylactic	compound	for	oxidative	diseases	
(Bjelakovic	et	al.,	2008).		
Flavonoids:	
Increased	 consumption	 of	 fruits	 and	 vegetables	 is	 associated	with	 reduced	 incidences	 of	 CAD	
and	other	disease.	 The	 cause	of	 this	has	been	attributed	 in	part,	 to	antioxidant	 Flavonoids	present	 in	
these	foods.	The	hypothesis	in	this	case	is	that	because	after	the	consumption	of	Flavonoids	there	is	a	
marked	 increase	 in	 the	 antioxidant	 properties	 of	 blood	 plasma	 and	 it	 can	 play	 a	 direct	 role	 in	 the	
prevention	of	 lipid	oxidation	 (Lotitoa	&	Frei,	2006).	A	clear	example	of	 this	 can	be	seen	 in	 the	French	
paradox,	where	despite	the	French	consuming	 large	amounts	of	red	meat	that	are	rich	 in	unsaturated	
fats	 they	still	develop	 lower	 instances	of	death	from	CAD	then	Americans.	This	has	been	attributed	to	
their	consumption	of	red	wine	which	is	rich	in	Flavonoids	(Ferrières,	2004).		
Michael	Aviram	of	the	Technion	faculty	of	medicine	has	done	extensive	research	in	the	field	of	
pomegranate	polyphenols	(Flavonoids),	and	has	made	a	very	important	contribution	to	the	field.	Among	
the	 points	 studied	 three	will	 be	 focused	 on:	 	 Antioxidant	 properties	 of	 blood	 plasma,	 paraoxonase-1	
(PON-1)1	levels,	and	aortic	stenosis	-	all	after	the	ingestion	of	PJ.	In	one	study	(Aviram,	et	al.,	2000),	both	
healthy	 human	 males	 and	 atherosclerotic	 E-deficient	 (E0)	 mouse	 subjects	 were	 fed	 PJ	 for	 variable	
periods	 of	 time.	 The	 objective	 of	 the	 study	 was	 to	 determine	 what	 effect	 PJ	 consumption	 had	 on	
lipoprotein	oxidation,	aggregation	and	retention;	macrophage	atherogenicity;	platelet	aggregation;	and	
atherosclerosis.	The	results	of	the	study	were	striking.	In	humans,	PJ	consumption	resulted	in	a	decrease	
in	 LDL	 susceptibility	 to	 aggregation	 (-11%	 ex	 vivo)	 and	 retention,	 also	 observed	 was	 serum	 PON-1	
increased	activity	by	20%	and	that	it	also	had	a	protective	effect	against	LDL	oxidation.	Human	plasma	in	
																																								 																				
1 Paraoxonase1	(PON1)	is	an	anti-inflammatory	enzyme	located	on	HDL.		
64	
	
one	 case	 showed	a	decrease	 in	 lipid	plasma	peroxidation	of	 ≤33%.	 In	 E0	mice,	 a	 90%	decrease	 in	 LDL	
oxidation	was	observed	as	well	as	a	20%	decrease	in	the	uptake	of	LDL	by	peritoneal	macrophages.	Also	
observed	 was	 a	 44%	 decrease	 in	 atherosclerotic	 lesions	 and	 foam	 cells	 as	 compared	 with	 water	 fed	
mice.	Aviram	et	 al.,	 attributes	 the	protective	 antioxidant	 effect	of	 PJ	 to	 increased	 cellular	 glutathione	
content,	 and	 states	 that	 the	 reduction	 of	 atherosclerotic	 lesions	 is	 directly	 related	 to	 the	 antioxidant	
properties	 of	 PJ.	 Another	 study	 by	 Aviram	 of	 the	 long	 term	 effects	 of	 PJ	 consumption	 -	 in	 human	
subjects	with	carotid	artery	stenosis	(CAS)	-	on	carotid	lesions	and	changes	in	oxidative	stress	and	blood	
pressure	had	 remarkable	 results.	After	 1	 year	 control	 subjects	 showed	a	9%	 increase	 in	 intima-media	
thickness	(IMT)	as	opposed	to	the	PJ	group	that	showed	a	30%	decrease	in	IMT.	PON-1	activity	increased	
by	83%,	serum	LDL	basal	oxidative	state	was	reduced	by	90%,	copper	ion	induced	oxidation	was	reduced	
by	59%	and	total	antioxidant	status	(TAS)	 increased	by	130%.	Again,	Aviram	attributes	these	results	to	
the	antioxidant	characteristics	of	PJ	polyphenols	(Aviram,	et	al.,	2004).		
Jane	Higdon,	 Ph.D.	 of	 The	 Linus	 Pauling	 Institute	 at	Oregon	 State	University	 takes	 a	 different	
tack	 and	 claims	 that	 because	 the	 bioavailability	 of	 Flavonoids	 is	 very	 low,	 its	 antioxidant	 properties	
cannot	 be	 attributed	 to	 the	 antioxidant	 properties	 proved	 in	 vitro.	 For	 example,	 the	bioavailability	 of	
Flavonoids	in	vivo	is	100-1000	times	lower	than	the	bioavailability	of	vitamin	C	or	glutathione	and	thus	
has	a	 very	 small	 antioxidant	effect.	However,	 it	 is	 available	 in	 concentrations	 that	effect	 cell	 signaling	
proteins.	 “Numerous	 studies	 in	 cell	 culture	 suggest	 that	 flavonoids	 may	 affect	 chronic	 disease	 by	
selectively	 inhibiting	kinases”	 including	 those	 related	 to	growth	 factors.	Higdon	hypothesizes	 that	 it	 is	
this	property	 that	protects	against	CAD	by	decreasing	 inflammation,	decreasing	vascular	cell	adhesion	
molecule	 expression,	 increasing	 endothelial	 nitric	 oxide	 synthase	 (eNOS)	 activity,	 and	 decreasing	
platelet	aggregation	(Higdon,	2005).	Another	study	(Lotito	&	Frei,	2006),	attributes	the	protective	effect	
of	 Flavonoids	 not	 directly	 to	 its	 antioxidant	 activity,	 but	 rather	 to	 the	 consequence	 of	 increased	 uric	
acid.2	What	 is	clear	from	all	these	studies	 is	that	 it	 is	not	the	antioxidant	properties	of	Flavonoids	that	
directly	 protect	 against	 CAD	 but	 rather	 to	 a	 whole	 host	 of	 activities	 including:	 increased	 native	
antioxidants	 such	as	glutathione,	uric	acid,	modified	cell	 signaling	pathways,	 increased	PON-1	activity,	
and	increased	NO	levels.			
Possible	Risks	of	Antioxidants	vs.	Flavonoids:	
So	then	what	really	does	account	for	the	differences	 in	Flavonoids	and	for	example	vitamin	E?	
What	may	be	at	play	is	as	follows:		
Vitamin	E	as	well	as	having	antioxidant	properties	is	a	pro-oxidant	as	well	(Bowry	et	al.,	1992).	
For	example:	instead	of	the	termination	reaction	by	tocopherol	to	the	oxidative	chain	reaction	of	lipids	
as	a	final	step:		
LOO•	+	TOH	→	LOOH	+	TO•	[4]	
We	instead	form	
																																								 																				
2 Recent	studies	have	implicated	hyperuricemia	as	being	a	true	risk	factor	in	development	of	cardiovascular	
disease	(Jing	Fang	&	Michael	H.	Alderman,	2000).	However,	nearly	half	of	the	bodies’	antioxidant	activity	is	from	
uric	acid	and	in	moderation	may	play	a	positive	role.					
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TO•	+	LH	→	TOH	+L•	[5]	
This	will	then	feed	into	the	chain	reaction	
L•	+	O2	→	LOO•	[2]	
LOO•	+	LH	→	LOOH	+	L•	[3]	
One	study	(Bowry,	Ingold,	&	Stocker,	1992)	has	found	that	in	aqueous	solution,	strikes	between	
the	stable	TO•	and	other	radicals	were	 found	to	 take	upward	of	17	minutes,	a	 time	 long	enough	that	
even	 the	 most	 stable	 radical	 will	 find	 “`something	 to	 do’”	 i.e.	 propagate	 the	 chain	 reaction.	 The	
termination	of	this	reaction	must	then	rely	on	two	endogenous	antioxidants	vitamin	C,	as	demonstrated	
by	 the	 thiol	 redox	 cycles	 (Appendix	 1),	 and	 ubiquinol	 (Q10H2,	 a	 reduced	 form	 of	 Q10)	 in	 the	 electron	
transport	chain.	What	can	be	inferred	from	this	is	that	by	ingesting	vitamin	E	the	body	sets	off	a	cascade	
of	endogenous	antioxidants,	 in	order	 to	minimize	 the	damage	being	 incurred	by	vitamin	E.	While	 the	
body	does	have	the	mechanisms	of	scavenging	TO•	how	can	making	more	of	them	by	ingesting	vitamin	
E	be	advantageous?	Essentially	 there	 is	a	delicate	balance	of	electron	radicals	 that	are	passed	down	a	
cascade	 until	 they	 can	 be	 neutralized	 to	 a	 non	 reactive	 end	 product,	 and	 by	 adding	 more	 electron	
radicals	in	the	form	of	α-tocopherol	it	may	have	the	effect	of	being	counterproductive.	
C	-	reactive	protein	and	PON-1	
By	contrast,	Flavonoids	are	effective	not	by	acting	as	antioxidants	but	through	modulating	the	
inflammatory	response	of	oxidized	cells.			
The	relationship	between	C	-	reactive	protein	(CRP)	and	Flavonoids	illustrates	this	point.	CRP	is	
found	to	be	elevated	during	 inflammatory	response	by	the	body,	specifically,	macrophages	and	T	cells	
release	 Interleukin-6	 (IL-6)	 as	 a	 pro	 inflammatory	 to	 stimulate	 a	 response	 to	 tissue	 damage.	 CRP	
production	is	then	part	of	the	acute-phase	response	to	most	forms	of	inflammation,	infection,	and	tissue	
damage.	 CRP	 levels	 by	 themselves	 cannot	 be	used	 as	marker	 for	 atherosclerosis,	 but	 they	have	been	
positively	correlated	with	CAD	(Pepys	&	Hirschfield,	2003).	Flavonoids	have	an	inverse	relationship	with	
CRP.	 One	 study	 using	 demographic	 data	 (Chun	 et	 al.,	 2008)	 found	 that	 the	 greater	 consumption	 of	
Flavonoid	rich	foods,	the	lower	the	concentrations	of	serum	CRP	thus	clearly	indicating	that	Flavonoids	
affect	 inflammatory	response.	 	Another	study	has	also	found	an	inverse	relationship	between	levels	of	
CRP	 and	 levels	 of	 PON-1	 expression.	 They	 found	 that	 “Higher	 levels	 of	 CRP	 seem	 to	 be	 generally	
associated	 with	 low	 levels	 of	 PON1	 activity”	 (Macknessa	 et	 al.,	 2006).	 Which	 should	 lead	 to	 the	
conclusion	that	the	atherosclerotic	protection	associated	with	Flavonoids	 is	not	related	to	an	 inherent	
antioxidant	activity	but	rather	to	other	factors	as	mentioned.				
Another	study	also	found	that	polyphenols	(i.e.	Flavonoids)	acutely	enhanced	nitric	oxide	bioactivity.	NO	
is	 necessary	 to	 maintain	 vasodilatation	 -	 the	 lack	 of	 which	 is	 implicated	 in	 increased	 risk	 of	
cardiovascular	disease	(Anter	et	al.,	2004).		
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Conclusions:	
In	 comparing	 the	 protective	 effects	 on	 atherosclerosis	 associated	with	 statins,	 vitamin	 E,	 and	
Flavonoids,	there	are	many	questions	as	to	the	ability	of	statins	and	vitamin	E	to	afford	real	protection	
against	 atherosclerosis.	 The	data	 in	many	 cases	 implicates	 these	 very	 compounds	 increased	mortality	
rates.	 By	 contrast,	 Flavonoids	 have	 shown	 themselves	 able	 to	 boost	 the	 bodies’	 native	 antioxidants	
including	uric	acid	and	glutathione,	while	at	the	same	time	reducing	the	inflammatory	response	to	the	
uptake	of	oxidized	lipids.	It	could	be	that	mother	really	knew	best	all	along	“an	apple	a	day	–	really	does	
–	keep	the	doctor	away”.	 (Apple	peals	have	been	found	to	consist	of	40%	flavonols	by	weight	 (Łata	&	
Tomala,	2007	)).		
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